Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Altimmune, Inc. Director's Dealing 2026

Feb 3, 2026

33207_dirs_2026-02-03_2dd2d220-dae2-4eec-8f5b-3f257309ab7c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2026-01-30

Reporting Person: Roberts M Scot (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-01-30 Common Stock, par value $0.0001 M 9275 Acquired 104670 Direct
2026-01-30 Common Stock, par value $0.0001 F 2859 $5.60 Disposed 101811 Direct
2026-01-31 Common Stock, par value $0.0001 A 5567 $3.07 Acquired 107378 Direct
2026-02-02 Common Stock, par value $0.0001 M 7775 Acquired 115153 Direct
2026-02-02 Common Stock, par value $0.0001 F 2329 $5.55 Disposed 112824 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-01-30 Restricted Stock Units $ M 9275 Disposed Common Stock, par value $0.0001 (9275) Direct
2026-02-02 Restricted Stock Units $ M 7775 Disposed Common Stock, par value $0.0001 (7775) Direct

Footnotes

F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.

F2: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.

F3: These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2025 through January 31, 2026.

F4: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2025.

F5: The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.

F6: The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.